Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02147353 · ClinicalTrials.gov registry record · NA
Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% Ointment
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02147353 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 42 participants.
The verdict
NCT02147353, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
External Genital Warts (EGW) are the most common sexually transmitted disease associated with more than 30 types of the Human Papillomavirus (HPV). Cryotherapy is an effective method of EGW treatment. However, multiple sessions may be required with reported clearance rates ranging between 27-88%. Sinecatechins 15% ointment is Food and Drug Administration approved for three times daily application in immunocompetent subjects 18 years and older for the treatment of EGW and perianal warts. Treatment of EGW with cryotherapy followed by sinecatechins appears to be logical. Cryotherapy has direct cytodestructive effects with immediate short-term efficacy on treated EGW, while sinecatechins provide field therapy, treating both clinical and sub-clinical lesions. For this study, the investigators used sinecatechins 15% ointment twice daily regimen and anticipated that the synergistic effect with cryotherapy will provide better efficacy that cryotherapy alone. The investigators also anticipated that the sequential therapy with be safe.
Interventions
- DRUG Sinecatechins 15% Ointment
- DRUG Cryotherapy alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02147353
The ClinicalTrials.gov registry entry for NCT02147353 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sinecatechins 15% Ointment is the first listed.
NCT02147353 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02147353 about?
NCT02147353 is a clinical study titled "Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% Ointment". External Genital Warts (EGW) are the most common sexually transmitted disease associated with more than 30 types of the Human Papillomavirus (HPV). Cryotherapy is an effective method of EGW treatment. However, multiple sessions may be required with reported clearance rates ranging between 27-88%. Si...
What is the current status of trial NCT02147353?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2011-09. Estimated completion is 2012-12.
What interventions are being tested in trial NCT02147353?
The interventions under investigation include: Sinecatechins 15% Ointment (DRUG), Cryotherapy alone (DRUG).
Who is sponsoring clinical trial NCT02147353?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.